drugset / Trial / NCT01336959

Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery

NCT01336959

Phase 2 Terminated 91 enrolled Mereo BioPharma Novartis · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will assess the safety and efficacy of BCT197 on acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypass.

Timeline

Start
2011-09
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Acumapimod Small molecule 10 mg
Subject Acumapimod Small molecule 50 mg

Indications